CJC-1295 (No DAC) Ipamorelin Blend Peptide
Це CJC-1295 (No DAC) / Ipamorelin Blend Peptide is a popular combination studied in peptide research for its ability to support the body’s natural growth hormone (GH) release. By pairing two complementary peptides, researchers often explore how this blend may influence recovery, metabolism, and overall performance-related pathways.
CJC-1295 (No DAC) is a growth hormone–releasing hormone (GHRH) analog that signals the pituitary gland to stimulate GH production. Іпаморелін, on the other hand, is a selective growth hormone secretagogue that activates ghrelin receptors, encouraging additional GH release without significantly increasing cortisol or prolactin levels. When used together, these peptides may help promote a more natural pulsatile release of growth hormone.
| Номер CAS | •CJC-1295 (No DAC): 863288-34-0
• Іпаморелін: 170851-70-4 |
| Інші назви | CJC-1295 (No DAC) and Ipamorelin 5mg/5mg Blend |
| Назва IUPAC | •CJC-1295 (No DAC): 4-[[1-[[1-[[1-[[1-[[5-amino-1-[[1-[[1-[[1-[[6-amino-1-[[1-[[1-[[1-[[5-amino-1-[[1-[[1-[[1-[[1-[[6-amino-1-[[1-[[1-[[5-amino-1-[[1-[[1-[[1-[[1-[(1-amino-5-carbamimidamido-1-oxopentan-2-yl)amino]-3-hydroxy-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxohexan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-[2-[[2-amino-3-(4-hydroxyphenyl)propanoyl]amino]propanoylamino]-4-oxobutanoic acid •Ipamorelin: |
| Молекулярна формула | •CJC-1295 (No DAC): C₁₅₂H₂₅₂N₄₄O₄₂
•Ipamorelin: C₃₈H₄₉N₉O₅ |
| Молекулярна маса | •CJC-1295 (No DAC): 3367.9
•Іпаморелін: 711,9 |
| Чистота | ≥99% Pure (LC-MS) |
| Наявність порошку | CJC-1295 No DAC 5mg/Ipamorelin 5mg (10mg total) peptide vial (lyophilized/freeze-dried) |
| Умови зберігання | Зберігати в охолодженому вигляді, тримати в холодильнику. НЕ заморожувати. |
| Умови | Уся продукція призначена ЛИШЕ для лабораторних досліджень і розробок. Продукція не призначена для споживання людиною. |
This blend has gained attention in research settings where scientists investigate muscle recovery, fat metabolism, sleep quality, and cellular repair. Because both peptides work through different biological pathways, the combination is often studied for its potential synergy in supporting regenerative processes.
Each vial is typically produced in controlled laboratory conditions to ensure purity, stability, and consistency for research applications.
Note: This peptide blend is intended strictly for research and laboratory use only.
ЧаПи
What is the CJC-1295 / Ipamorelin blend used for?
It is commonly studied in research related to growth hormone release, recovery, metabolism, and performance.
How does this peptide blend work?
CJC-1295 stimulates growth hormone release from the pituitary gland, while Ipamorelin activates ghrelin receptors to enhance GH secretion.
Why are these peptides combined?
Researchers often combine them to explore potential synergistic effects that may support natural hormone signaling.
How should peptide blends be stored?
Peptides are typically stored in a прохолодне, сухе місце and refrigerated after reconstitution to maintain stability.

Пептид ACE-167 30 мл рідина (5 мг/мл, флакон 150 мг)
ПЕПТИД P21 25МГ РІДКИЙ СПРЕЙ ФЛАКОН 15МЛ (250МКГ/СПРЕЙ, 25МГ ЗАГАЛОМ)
ПТ-141 БРЕМЕЛАНОТИД ПЕПТИД 40МГ РІДКИЙ СПРЕЙ 15МЛ ФЛАКОН (1МГ/2 СПРЕЇ, ЗАГАЛОМ 40МГ)
ПЕПТИД МЕЛАНОТАН II 10 МГ РІДКИЙ СПРЕЙ ФЛАКОН 15 МЛ (100 МКГ/СПРЕЙ, ВСЬОГО 10 МГ) 





Відгуки
Відгуків немає, поки що.